Literature DB >> 18587722

Hepatitis C virus infection as a risk factor for increased aortic stiffness and cardiovascular events in dialysis patients.

Nobuyuki Oyake1, Toshio Shimada, Yo Murakami, Yutaka Ishibashi, Hidetoshi Satoh, Keiko Suzuki, Akira Matsumory, Teiji Oda.   

Abstract

BACKGROUND: Although links have been found between microorganisms and cardiovascular diseases, the role of hepatitis C virus (HCV) infection in the pathogenesis of arteriosclerosis and cardiovascular events is unclear. The primary objective of this research was to examine whether HCV infection is associated with increased aortic stiffness and cardiovascular events in chronic hemodialysis patients. SUBJECTS AND METHODS: A prospective cohort study was conducted in 94 dialysis outpatients from October 2002 to October 2004. Measurements included carotid-femoral pulse wave velocity (PWV), echocardiographic parameters, serum HCV-RNA (positive in 17 patients), and several items of biochemical data. Multiple logistic regression and the Cox proportional hazard model were used to assess independent determinants of high aortic PWV (> or =10.0 m/sec, mean) and cardiovascular events (including cerebral and peripheral vascular events), adjusting for several risk factors and duration of dialysis.
RESULTS: The HCV-positive group had higher aortic PWV and lower serum cholesterol levels. Multivariate analysis indicated mean blood pressure, hemoglobin A1c and HCV viremia to be independent determinants of high PWV. During the follow-up period, 13 patients suffered from cardiovascular events. Prevalence of the diseases at baseline, pulse pressure, left ventricular mass index, HCV viremia and aortic PWV were associated with cardiovascular events. The Kaplan-Meier analysis indicated a significant difference in event-free rates between HCV-positive and HCV-negative patients.
CONCLUSION: HCV infection is closely associated with increased aortic stiffness and cardiovascular event in dialysis patients.

Entities:  

Mesh:

Year:  2008        PMID: 18587722

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  11 in total

Review 1.  Hepatitis C in hemodialysis patients.

Authors:  Smaragdi Marinaki; John N Boletis; Stratigoula Sakellariou; Ioanna K Delladetsima
Journal:  World J Hepatol       Date:  2015-03-27

2.  Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients.

Authors:  Chung-Feng Huang; Ming-Yen Hsieh; Jeng-Fu Yang; Wu-Cheng Chen; Ming-Lun Yeh; Ching-I Huang; Chia-Yen Dai; Ming-Lung Yu; Zu-Yau Lin; Shinn-Chern Chen; Wan-Long Chuang; Jee-Fu Huang
Journal:  Hepatol Int       Date:  2010-08-04       Impact factor: 6.047

3.  Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.

Authors:  L Kakinami; R C Block; M J Adams; S E Cohn; B Maliakkal; S G Fisher
Journal:  Int J Clin Pract       Date:  2013-01       Impact factor: 2.503

4.  Does hepatitis C virus infection increase risk for stroke? A population-based cohort study.

Authors:  Chien-Chang Liao; Ta-Chen Su; Fung-Chang Sung; Wan-Hsin Chou; Ta-Liang Chen
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

Review 5.  Hepatitis C virus infection and dialysis: 2012 update.

Authors:  Fabrizio Fabrizi
Journal:  ISRN Nephrol       Date:  2012-12-17

Review 6.  Atherosclerosis as a possible extrahepatic manifestation of chronic hepatitis C virus infection.

Authors:  Nobukazu Ishizaka; Yuko Ishizaka; Minoru Yamkado
Journal:  Clin Med Insights Cardiol       Date:  2014-11-12

7.  The effect of Hepatitis C Virus infection on cardiovascular complications in end stage kidney disease patients on regular hemodialysis.

Authors:  Mohamed Salah Eldin Zaki
Journal:  Electron Physician       Date:  2017-02-25

Review 8.  Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review.

Authors:  Ahmed Babiker; Jean Jeudy; Seth Kligerman; Miriam Khambaty; Anoop Shah; Shashwatee Bagchi
Journal:  J Clin Transl Hepatol       Date:  2017-08-31

9.  Seroprevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among hemodialysis patients in a Tertiary Care Teaching Hospital in a developing country.

Authors:  Sonam Kansay; Jannat Sekhon; Saifi Rana
Journal:  Indian J Sex Transm Dis AIDS       Date:  2019 Jul-Dec

10.  Changes in Office Blood Pressure Control, Augmentation Index, and Liver Steatosis in Kidney Transplant Patients after Successful Hepatitis C Infection Treatment with Direct Antiviral Agents.

Authors:  Aureliusz Kolonko; Joanna Musialik; Jerzy Chudek; Magdalena Bartmańska; Natalia Słabiak-Błaż; Agata Kujawa-Szewieczek; Piotr Kuczera; Katarzyna Kwiecień-Furmańczuk; Andrzej Więcek
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.